Venrock Healthcare Capital Partners III, L.P.

10% owner at Oruka Therapeutics, Inc. · on record since Feb 27, 2025
10% owner at Bellerophon Therapeutics, Inc. · on record since Sep 17, 2018
10% owner at KalVista Pharmaceuticals, Inc. · on record since Sep 10, 2018
10% owner at CONSTAR INTERNATIONAL INC · on record since Dec 16, 2019
10% owner at Synvista Therapeutics, Inc. · on record since May 28, 2020
10% owner at Tricida, Inc. · on record since Jun 30, 2022
10% owner at Vistagen Therapeutics, Inc. · on record since Jul 14, 2022
10% owner at Cogent Biosciences, Inc. · on record since Aug 18, 2020

Insider trading activity of Venrock Healthcare Capital Partners III, L.P.

Transactions on record: 19; since Sep 12, 2018

Open-market buys: 16; $7M

Open-market sells: 3; $524.1K

Companies traded: 3; last filing Feb 11, 2025

Figures computed from official regulatory filings — .

Companies where Venrock Healthcare Capital Partners III, L.P. has traded

KalVista Pharmaceuticals, Inc.10 tx · $5.3M · Feb 11, 2025
Cogent Biosciences, Inc.3 tx · $1.1M · Aug 18, 2020
Bellerophon Therapeutics, Inc.6 tx · $1.1M · Oct 28, 2019

Track record of Venrock Healthcare Capital Partners III, L.P.

Statistical track record

Free account

Open-market buys: 16

Last buy: Feb 11, 2025

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Venrock Healthcare Capital Partners III, L.P.

Co-insiders of Venrock Healthcare Capital Partners III, L.P.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
KalVista Pharmaceuticals, Inc.Listing unverified	Feb 11, 2025	Buy	26,703	9.18 USD	$245.1K	conv 20	SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Feb 11, 2025	Buy	4,137	9.14 USD	$37.8K	conv 19	SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Feb 11, 2025	Buy	73,649	9.29 USD	$684.2K	conv 38First in 12mo	SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Feb 1, 2024	Buy	88,099	14.47 USD	$1.3M	conv 52ClusterUnusual size	SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Jan 29, 2024	Buy	7,030	12.73 USD	$89.5K	conv 33Cluster	SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Jan 29, 2024	Buy	80,600	14.22 USD	$1.1M	conv 56ClusterUnusual size	SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Jan 29, 2024	Buy	4,174	12.98 USD	$54.2K	conv 33Cluster	SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Jan 10, 2024	Buy	20,816	12.56 USD	$261.4K	conv 33Cluster	SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Jan 10, 2024	Buy	69,184	12.44 USD	$860.6K	conv 67ClusterUnusual size+1	SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Jan 10, 2024	Buy	47,700	12.67 USD	$604.4K	conv 40Cluster	SEC
Cogent Biosciences, Inc.Listing on record	Aug 18, 2020	Buy	100,000	2.30 USD	$230K	conv 25First in 12mo	SEC
Cogent Biosciences, Inc.Listing on record	Aug 18, 2020	Buy	250,000	2.57 USD	$642.5K	conv 35Unusual size	SEC
Cogent Biosciences, Inc.Listing on record	Aug 18, 2020	Buy	101,000	2.62 USD	$264.6K	conv 7	SEC
Bellerophon Therapeutics, Inc.Listing unverified	Oct 28, 2019	Sell	-333,010	0.44 USD	$146.5K		SEC
Bellerophon Therapeutics, Inc.Listing unverified	Oct 28, 2019	Sell	-56,242	0.45 USD	$25.3K		SEC
Bellerophon Therapeutics, Inc.Listing unverified	Oct 28, 2019	Sell	-704,595	0.50 USD	$352.3K		SEC
Bellerophon Therapeutics, Inc.Listing unverified	Sep 12, 2018	Buy	200,000	1.14 USD	$228K	conv 34Cluster	SEC
Bellerophon Therapeutics, Inc.Listing unverified	Sep 12, 2018	Buy	75,000	1.15 USD	$86.3K	conv 33Cluster	SEC
Bellerophon Therapeutics, Inc.Listing unverified	Sep 12, 2018	Buy	200,000	1.22 USD	$244K	conv 42ClusterFirst in 12mo	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
KalVista Pharmaceuticals, Inc.Listing unverified	Feb 11, 2025	Buy	26,703	9.18 USD	$245.1K	conv 20	SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Feb 11, 2025	Buy	4,137	9.14 USD	$37.8K	conv 19	SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Feb 11, 2025	Buy	73,649	9.29 USD	$684.2K	conv 38First in 12mo	SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Feb 1, 2024	Buy	88,099	14.47 USD	$1.3M	conv 52ClusterUnusual size	SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Jan 29, 2024	Buy	7,030	12.73 USD	$89.5K	conv 33Cluster	SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Jan 29, 2024	Buy	80,600	14.22 USD	$1.1M	conv 56ClusterUnusual size	SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Jan 29, 2024	Buy	4,174	12.98 USD	$54.2K	conv 33Cluster	SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Jan 10, 2024	Buy	20,816	12.56 USD	$261.4K	conv 33Cluster	SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Jan 10, 2024	Buy	69,184	12.44 USD	$860.6K	conv 67ClusterUnusual size+1	SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Jan 10, 2024	Buy	47,700	12.67 USD	$604.4K	conv 40Cluster	SEC
Cogent Biosciences, Inc.Listing on record	Aug 18, 2020	Buy	100,000	2.30 USD	$230K	conv 25First in 12mo	SEC
Cogent Biosciences, Inc.Listing on record	Aug 18, 2020	Buy	250,000	2.57 USD	$642.5K	conv 35Unusual size	SEC
Cogent Biosciences, Inc.Listing on record	Aug 18, 2020	Buy	101,000	2.62 USD	$264.6K	conv 7	SEC
Bellerophon Therapeutics, Inc.Listing unverified	Oct 28, 2019	Sell	-333,010	0.44 USD	$146.5K		SEC
Bellerophon Therapeutics, Inc.Listing unverified	Oct 28, 2019	Sell	-56,242	0.45 USD	$25.3K		SEC
Bellerophon Therapeutics, Inc.Listing unverified	Oct 28, 2019	Sell	-704,595	0.50 USD	$352.3K		SEC
Bellerophon Therapeutics, Inc.Listing unverified	Sep 12, 2018	Buy	200,000	1.14 USD	$228K	conv 34Cluster	SEC
Bellerophon Therapeutics, Inc.Listing unverified	Sep 12, 2018	Buy	75,000	1.15 USD	$86.3K	conv 33Cluster	SEC
Bellerophon Therapeutics, Inc.Listing unverified	Sep 12, 2018	Buy	200,000	1.22 USD	$244K	conv 42ClusterFirst in 12mo	SEC